Biobot Surgical
Derrick Yong currently serves as the Head of Scientific Affairs at Biobot Surgical following a secondment from A*STAR that began in December 2023. As a Senior Scientist at A*STAR since April 2023, Derrick also holds the position of Adjunct Assistant Professor at the National University of Singapore and Co-Principal Investigator at the Singapore-MIT Alliance for Research & Technology Centre. Derrick's previous roles include General Manager, R&D Lead, and Senior Research Lead in Optics at Endofotonics (November 2021 - November 2023), where progress was made in optics design and instrumentation for fluorescence imaging and optical spectroscopy. Derrick's accomplishments include securing multiple industry partnerships, leading significant research projects, and facilitating the education of numerous students. Derrick earned a PhD and a Bachelor of Engineering in Bioengineering from Nanyang Technological University Singapore.
This person is not in any teams
Biobot Surgical
At Biobot Surgical, our mission is to revolutionize the realm of robotic-assisted biopsy and treatment for prostate cancer. As the landscape for prostate cancer treatment evolves, we aren’t just riding this wave of change — we’re propelling it, ushering in a new era of excellence in prostate disease management. At the forefront of these advances in the standard of care in prostate cancer management, we are poised to address the global unmet need for a precise approach to transperineal procedures — and make a monumental impact on the lives of patients. Our first- and best-in-class surgical robot iSR’obot Mona Lisa has obtained key regulatory approvals, including Europe (CE mark), the US (FDA), Australia (TGA), and Singapore (HSA), and is being used in some of the most prestigious hospitals around the world. We remain committed to advancing innovation in the field of robotic-assisted transperineal biopsy and treatment, and delivering the precision urologists require—and patients deserve.